Explore the vast range of titles available.

Eadweard Muybridge is among the seminal originators of the contemporary world's visual form.Projectionists examines mostly unknown aspects of Muybridge's work: his period as a touring projectionist who enthralled audiences with unprecedented moving-images and his creation of a moving-image auditorium--long before cinemas--in which to project his.

When his friend Spencer, the class genius, spends the night, he and Zack discover how to leave their bodies and travel around New York City, but they have one problem--how to get back inside themselves.

ObjectivesThe aim of this study was to compare image quality of single-source dual-energy CT (SS-DECT) with third-generation dual-source dual-energy CT (DS-DECT) in head and neck cancer.Materials and methodsOne hundred two patients with histologically proven head and neck cancer were prospectively randomized to undergo radiation dose-matched SS-DECT (n = 51, 120 kV, split-filter technique, 384 ref. mAs) or DS-DECT (n = 51, 80/Sn150 kV, tube A 100/tube B 67 ref. mAs). Inline default images (DI) and virtual monoenergetic images (VMI) for two different low energies (40 and 60 keV) were reconstructed. Objective image quality was evaluated as dose-normalized contrast to noise ratio (CNRD), and subjective image quality was rated on a 5-point Likert scale.ResultsIn both groups, highest CNRD values for vessel and tumor attenuation were obtained at 40 keV. DS-DECT was significantly better than SS-DECT regarding vessel and tumor attenuation. Overall subjective image quality in the SS-DECT group was highest on the DI followed by 40 keV and 60 keV. In the DS-DECT group, subjective image quality was highest at 40 keV followed by 60 keV and the DI. Forty kiloelectron volts and 60 keV were significantly better in the DS-DECT compared to the SS-DECT group (both p < 0.01).ConclusionsIn split-filter SS-DECT as well as in DS-DECT, highest overall image quality in head and neck imaging can be obtained with a combination of DI and low keV reconstructions. DS-DECT is superior to split-filter SS-DECT in terms of subjective image quality and vessel and tumor attenuation.Key Points• Image quality was diagnostic with both dual-energy techniques; however, the dual-source technique delivered significantly better results.• Highest overall image quality in head and neck imaging can be obtained with a combination of default images and low keV reconstructions with both dual-energy techniques.• The results of this study may have relevance for the decision-making process regarding replacement of CT scanners and focused patient examination considering image quality and subsequent therapeutic decision-making.

We introduce a very general method for high dimensional classification, based on careful combination of the results of applying an arbitrary base classifier to random projections of the feature vectors into a lower dimensional space. In one special case that we study in detail, the random projections are divided into disjoint groups, and within each group we select the projection yielding the smallest estimate of the test error. Our random-projection ensemble classifier then aggregates the results of applying the base classifier on the selected projections, with a data-driven voting threshold to determine the final assignment. Our theoretical results elucidate the effect on performance of increasing the number of projections. Moreover, under a boundary condition that is implied by the sufficient dimension reduction assumption, we show that the test excess risk of the random-projection ensemble classifier can be controlled by terms that do not depend on the original data dimension and a term that becomes negligible as the number of projections increases. The classifier is also compared empirically with several other popular high dimensional classifiers via an extensive simulation study, which reveals its excellent finite sample performance.

The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010–13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. Incidence rates for HIV, tuberculosis, and malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Bill & Melinda Gates Foundation.